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Background: The health management of patients with epilepsy could be improved by wearing devices 
that reliably detect when epileptic seizures happen. For the devices to be widely adopted, they must 
be acceptable and easy to use for patients and their views are very important. Previous studies have 
collected feedback from patients on hypothetical devices, but very few have examined experience of 
wearing actual devices.  
Purpose: This study assessed the first-hand experiences of people with epilepsy using wearable 
devices, continuously over a period of time. The aim was to understand how acceptable and easy they 
were to use, and whether it’s reasonable to expect that people will use them. 
Materials and Methods: Adults with a diagnosis of epilepsy admitted routinely to a hospital epilepsy 
monitoring unit were asked to wear one, or more, wearable biosensor devices, tested for seizure 
detection. The devices are designed to continuously monitor and record signals from the body (bio-
signals). Participants completed semi-structured interviews about their experiences of wearing the 
device(s). A systematic thematic analysis extracted themes from the interviews, focusing on 
acceptability and usability. Feedback was organised into 1) participants’ experiences of the devices, 
any support they required and reasons for stopping wearing them; 2) their thoughts about using this 
technology outside a hospital setting 
Results: Twenty-one people with epilepsy wore one, or more, wearable devices for an average of 
112.81 (SD=71.83) hours. Participants found the devices convenient, and had no problem wearing 
them in hospital or sharing the data collected from them with the researchers and medical 
professionals. However, the presence of wires, bulky size, discomfort and need for support, 
moderated experience. Participants’ thoughts about wearing them in everyday life were strongly 
influenced by how visible and perceived accuracy. Willingness to use a smartphone app to complete 
questionnaires depended on the frequency, number of questions and support.  
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Conclusions: Overall, this work provides evidence about the feasibility and acceptability of using 
wearable devices to monitor seizure activity in people with epilepsy. Key barriers and facilitators to 
use while in hospital and hypothetical use in everyday life were identified and will be helpful for 
guiding future implementation.  
Key words: epilepsy, acceptability, feasibility, qualitative analysis, wearables, seizure detection.   
 
Introduction 
Epilepsy is a common neurological condition that affects more than 50 million people globally [1]. It is 
associated with significant morbidity and mortality [2, 3]. Many important treatment decisions are 
based on the clinician reviewing the frequency and pattern of occurrence of seizures. These are usually 
self-reported by the person with epilepsy, for example in a seizure diary. However, there is good 
evidence that self-reported seizure occurrence may be inaccurate and unreliable [4-6]. 
 
It may be possible to reliably detect seizures by tracking physiological and behavioural variables in a 
person, for example, their heart rate, movements and electrical conductance of the skin. These might 
change before, during and after a seizure [7, 8]. Remote health technologies may be used, using 
biosensors that continuously monitor and record signals from the body. These can detect seizures and 
make a reliable log of epileptic activity. The data collected can be shared with medical professionals. 
The sensors can be built into clothing or devices that are worn continuously, known as ‘wearables’.[9].  
 
Although there is growing evidence of the ability of wearables to detect seizures [e.g., 10, 11] there is 
much less data on whether wearing such devices is acceptable to people with epilepsy. Preliminary 
surveys suggest that about 80-94% are interested in using them to track seizures. They are open to 
different forms of wearables, including wrist worn devices and patch electrodes (stuck on the skin) [8, 
12]. However, previous research also suggests that wearables should be inconspicuous, unobtrusive, 
non-stigmatising, comfortable to wear and attractively designed [13, 14]. These criteria are not always 
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the top priority when the devices are being designed. In addition, people with epilepsy have voiced 
concerns about the confidentiality of data collected [8] although others have suggested that this is 
less of a problem [15]. Technical assistance and clinical support, for example from a doctor, have also 
been highlighted as extremely important in making the device more acceptable. [8, 14]. 
 
The purpose of this study was to evaluate acceptability of wearable devices in people with epilepsy, 
specifically in individuals who have used them, rather than discussing idealised, theoretical devices. 
This is a novel study that explores users’ experience of wearables worn on the wrist, arm or head, 
while undergoing a routine video-EEG assessment in a hospital epilepsy monitoring unit. We were also 
interested in participants’ views of using wearables and other technologies, for example smartphone 




This was an observational study involving semi-structured interviews following a topic guide, on 
acceptability of wearable sensor devices. The interviews were carried out after people with epilepsy 
had worn one, or more, wearable biosensors continuously, during a routine video-EEG assessment in 
a hospital epilepsy monitoring unit. The data were analysed using qualitative techniques.  
 
The interview and study procedures were approved by the London-Fulham Research Ethics 
Committee (16/LO/2209; IRAS project ID 216316).  
 
Participants 
Participants were eligible if they were between 18 and 80 years, had a diagnosis of epilepsy and were 
able to give informed consent. People were excluded if they had an established diagnosis of 
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Clinical and demographic information, such as age and seizure frequency, were collected. The 
interviews lasted up to 25 minutes and were audio-recorded. They were conducted by a trained 
Clinical Psychologist using a semi-structured framework covering: 
• Experiences of using the wearables 
• Support required while using the wearables 
• Concerns they may have, for example the comfort, appearance and data privacy/security 
• Reasons for stopping to wear a device 
• Thoughts about using technology, such as wearables and smartphone apps, outside hospital 
 
The devices 
Five wearable biosensors were used to monitor a range of bio-signals, alongside routine scalp EEG and 
video recordings. The E4 (Empatica Inc., Cambridge, MA, USA) and Everion (Biovotion AG, Zurich, 
Switzerland) devices were CE or FDA marked for human use and designed for continuous, real-time 
data acquisition in daily life. A bespoke sensor armband (IMEC, Leuven, Belgium), Epilog (Epitel Inc., 
Salt Lake City, UT, USA) and Sensor Dots (Byteflies NV, Antwerp, Belgium) were “research sensors”. 
Further characteristics of these devices are detailed in Table 1. Each participant was asked to self-
manage their devices where possible (e.g. turning them on and off and recharging if needed). The 
research team monitored how participants were doing every 24 hours and provided help when 
requested.   
 
 





Audio recordings were transcribed and then a thematic analysis was performed using NVivo Software 
Version 12. All transcripts were coded by two researchers working independently (A.B & S.S.) and the 




Forty-four patients with uncontrolled seizures were admitted for a long-term video-EEG in the 
Epilepsy Monitoring Unit at King’s College London between January 2018 and February 2019.  Twenty-
one participants were selected from this sample to be interviewed based on which devices they were 
wearing (we aimed to interview 5 or 6 people per device). They also had to be willing to take part, 
even if they had decided to remove the devices during the study.   
 
The characteristics of the 21 participants are summarized in Table 2. Five participants wore a single 
device, seven wore two devices (at the same time), and nine participants wore three devices (at the 
same time). As a result, each device was used a different number of times: Bespoke armband was 
worn sixteen times, E4 eight times, Everion six times, Sensor Dots five times, Epilog seven times. The 
average time wearing the devices across the entire sample was 112.81 (SD=71.83) hours. See 
supplementary file A for further details for each participant. Seven participants had previous 
experience of using a wearable bio-sensor device, for example a Fitbit, in their daily life.  
 






Participant experiences  
Information from the interviews was subdivided into experience of wearables in hospital and views 
on home-based use of technology. Under these topic headings, seven major themes and 22 minor 
themes emerged. Minor themes were broken down further into subthemes, where this helped 
understanding. These themes are summarised in Table 3 and are described in detail, with examples, 
below. A further deductive analysis was conducted, to extract the main 12 barriers to using the 
wearables and nine facilitators to engagement with each of the wearables (see Table 4 for more 
details). 
 
[Insert Table 3 here] 
 
[Insert Table 4 here] 
 
Experience of wearing devices in hospital 
Convenience and practicality of the devices 
The wearables were convenient and preferable to the EEG sensors placed on their head.  
 
‘I just think it’s a very good system and a lot easier to manage than like an EEG’ (Participant 6) 
 
‘EEG, it’s not been much of a difference before I got my arm bands, it just seems like another 
attachable thing to the EEG, but I would like, the devices I like, they’re just simple, you can take 
it off, put it back on, rather than the way this is on my head’ (Participant 12) 
 
Many people said that they had no problems with the wearables. However, some practical issues 
were raised as key considerations when speaking about acceptability, such as: 
• Visibility of the wearable, with people preferring discreet devices 
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• Support with fitting or switching on devices and charging. This mostly required help from the 
research team, which had very positive feedback. 
• Stability of the device. The strength of the adhesive to secure the wearables that are attached 
with patches was important for keeping them securely in place. In some cases, wearables 
came loose during the study. This was mostly a concern for the flexible position devices, such 
as wearables attached to the head, and this sometimes happened while sleeping or during a 
seizure.  
 
‘I found the ones on the head alright because they were out of my way, they were somewhat 
comfortable, the only issue with them is that after two days they started, well the glue started 
to wear off’ (Participant 18) 
 
Other devices, such as the armbands, were typically found to stay securely in place throughout the 
test period.  
 
The wearable that required additional wires/electrodes (the bespoke armband from IMEC), was more 
of a nuisance for some participants, especially when engaging in personal care activities. For example, 
it got caught on clothing. Some participants described a preference for other more removeable 
options, such as armbands without any wires (the Everion). 
 
‘the Biovotion it makes it easier cause then you don’t have the sort of the little sticky tabs as 





In one case (participant 1), some limits to the placement of wearables arose for medical reasons. This 
included the need to position devices away from a venous line site on the arm and because of previous 
injuries. 
 
Overall, comfort was of great importance. Someone commented that they had been undisturbed by 
the wearables, even during sleep. 
 
‘I thought I’d give it a go sleeping on it [Epilog], and it didn’t really make a difference sleeping 
on it last night, so yeah, all week like I was expecting it to, I’ve not slept on it, because I was 
expecting it to be like uncomfortable or end up coming off when I were sleeping or whatever, 
but yeah it didn’t end up coming off or whatever, it was just like a normal night’s sleep’ 
(Participant 19) 
 
However, some reported a skin irritation or discomfort with a Velcro arm band (both relating to the 
IMEC device). 
 
Appearance of the device also influenced experience. For the people who compared their experience 
to wearable devices they already owned, some said that the wrist band (E4) was similar to a previous 
smartwatch, others said it was larger. Preferences varied for the wrist band versus the arm bands 
within the group. Participants made observations that some wearables could be discreetly hidden 
under clothes, or were inconspicuous, or even fashionable, for example like a fitness tracker.  
 
Table 4 lists the barriers and facilitators extracted from the interviews, for each device. While there 
were challenges associated with all devices, on balance, there was a general preference for wrist and 




Views on sharing data 
Participants were asked about their views on data being automatically collected through the wearable 
devices. Most participants reported no problems and saw positives to sharing this information. One 
person pointed out the sensitivity around some types of personal data, including identity and 
location. They highlighted the importance of consent procedures in terms of setting up these 
arrangements. Participants thought that sharing data, such as mood, activity and number of seizures 
with healthcare professionals could lead to beneficial actions such as:  
• Adding information to medical records; 
• Pinpointing patterns; 
• Changing medication. 
 
Deciding to remove wearables 
Three participants were interviewed after deciding to remove the wearables. Their reasons varied. 
One reported discomfort in relation to an arm band (IMEC device) after 1 day. Another removed the 
same device due to confusion after experiencing a seizure. Another participant saw no benefit in 
continuing after 3 days of data collection with both flexible position devices (Sensor Dots and Epilog).  
 
Views on home-based technology use 
Use of wearable devices 
Many participants endorsed wearable devices as an interesting and good idea to try to detect seizures 
in real-time and be able to move around, in the hospital or at home. 
 
‘I think that having other devices, especially when you’re at home it’s also a better 





When asked about willingness to take part some agreed, but others said they were unwilling. For 
some, this was due to the effort required or pressure to commit to doing something. However, one 
person raised concerns about other people wanting the device and being the target of crime, for 
example, devices being stolen. Others were cautious about the questions that people might ask, 
including fear of discrimination. 
 
‘I wouldn’t wear a device on my arm where I live, they’d probably think I just got out of prison 
or something, it’s a very rough area, and it’s very, no I wouldn’t wear it. I’d wear it inside, but 
no, yeah ‘(Participant 1).  
 
Factors that were raised as important to user experience in hospital, for example comfort, 
convenience and ease of use, were also important to consider outside of hospital.  
‘I’d say if it’s comfortable and if it’s very easy to use then they’d be absolutely fine with it’ 
(Participant 18) 
 
Outside of hospital, wrist and arm worn devices were thought to be more acceptable than head worn 
devices because they were less visible.  
 
‘the big black plastic buttons on my head are a little bit weird, but given that I’m covered in 
strange, my head is covered in strange white wires, so big black buttons didn’t seem too 
dramatic. But yes, those would’ve looked a bit odd in isolation out on the streets. I mean saying 
that, the one on my neck is much less noticeable, and then I’ve got this thing on my arm which 
looks like the kind of thing people slot their iPhone into while they’re running, so that’s very 




Participants were divided about additional functions, such as a watch face. Some said it would be 
useful and others not. Overall, comfort and accuracy seem more important than any other additional 
functions, such as GPS or medication alerts. 
 
For some, there was an additional consideration of the length of time they would wear the device(s). 
Some thought that it could be worn only during specific time periods where it was more convenient 
or useful, such as at home and at night. Others were willing to wear a device for as long as it took, as 
long as the device was comfortable. It was suggested that the device might become part of a person’s 
routine.  
 
In relation to this, one person mentioned the importance of having family members to support him 
with the use of the device for a prolonged time at home: 
 
‘As long as I know how to do it, and I’m surrounded by family, so they’d be able to help me’ 
(Participant 17) 
 
It may be important to note that some felt that there would be the need for enough personal benefit, 
for example, the device being part of their medical care. 
 
‘if it was part of a longer study, just because of what I do and the other pressures I have on 
me, there would have to be a direct benefit to me as well’ (Participant 4) 
 
‘well I wouldn’t mind for a period of time maybe, um, comfort is important to me, um, I don’t 
mind so much but uh it does have a slight tendency to cause a little bit of itchiness and stuff 
like that so that might irritate me after a while, but I could wear it for a period of time if I 




Use of a smartphone app 
Participants were asked about using a smartphone app while they were wearing the device(s), to 
gather and display data.  People could see the value in this, for example to: 
• Reduce repetition of information 
• Know that the device is gathering data 
• Raise awareness of their health condition  
• Provide motivation, through feedback from the app 
They would be willing to complete simple questionnaires, but acceptability of the frequency of 
questionnaires varied between individuals. One person suggested that family members/carers might 
like to input into the system.  
 
‘If it takes a minute to fill in three times a day then that’s not much of a problem. But if it’s 
taking ten minutes each time then that would be too long’ (Participant 14) 
 
‘short questionnaire, cause otherwise people will think like, I’m getting up in the morning, 
daily routine and putting them on, and some people might also think okay now I’ve gotta go 
and do the app, so, I would probably say one a day, a short one, yeah’ (Participant 15) 
 
However, there were also concerns raised about barriers relating to digital exclusion, due to people 
not owning a smartphone, not being confident with using apps, or simply disliking them. 
 
‘I’m not particularly keeping up with things like apps you know, I’ve got apps on here, I know 
what they do, but already I’ve gone onto this [app] and its consumed so much of the storage 




A solution offered was to complete questionnaires using a computer.  
 
Discussion 
This is a novel study, where we collected user feedback from people with epilepsy after continuously 
wearing devices in an epilepsy monitoring unit. To the best of our knowledge, there are no previous 
studies reporting patients views on wearing multiple devices simultaneously for an extended time 
period. Each device had strengths and weaknesses that are very important for long-term use, and 
some devices were more tolerable than others. The provision of a removable but securely fitted device 
with a long battery life that looks familiar (like a watch or a fitness tracker), were preferable. Our 
participants were interested in the idea of using a wearable outside the hospital for an extended 
period. They acknowledged that wearing a device continuously in a natural setting could be the ideal 
solution for collecting more accurate data about seizures. Despite this, some participants suggested 
some barriers to wearing a device constantly. If the wearable were to be combined with a smartphone 
app, functions would have to be simple and quick to use. 
These findings build on previous research that focused on hypothetical scenarios and they echo, as 
well as extend, their conclusions. It has been repeatedly reported that motivation to use wearables 
will depend on the accuracy and reliability of the device to detect or predict seizures, with a low false 
positive/false negatives rates [8, 13, 14, 16]. In line with previous findings, participants in this study 
expressed preferences for devices that function without being too noticeable [12]. Additional 
wearable devices were all relatively discreet in hospital. However, when asked about wearing these 
devices in their daily life, people were not keen on wearing flexible position devices. Specifically, these 
were devices worn on the head, or with wires that could not be covered, or that looked out of place. 
Previous research has already highlighted problems with stigma associated with epilepsy, [14, 17] so 
the visibility of wearable devices will be key for the future use of this technology. Other barriers and 
facilitators to user experience are also in line with previous findings. For example, the need to consider 
devices with a long battery life and giving the user the ability to remove or charge the device by 
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themselves [13, 15, 16]. Some barriers were overcome with researcher support, but in a less 
controlled environment this may be more of a problem. Previous studies have suggested that users of 
wearables and smartphone are provided with technical support, in the form of written documents, 
video tutorials or telephone-based.[8, 13]. 
 
The interest in exploring the efficacy and accuracy of wearables for the detection and prediction of 
epileptic seizures is clear. There is a number of new studies emerging and devices available on the 
market [10, 18, 19]. Despite this, the use of wearables to improve health-management and safety in 
the routine of people with epilepsy is not yet realised. Only a small percentage of our participants 
were using, or had worn, a device to monitor their epilepsy (2/21 9%). An adequate level of 
acceptability and usability could be the key to obtain a suitable device for continuously detecting 




Participants were recruited from a sample of individuals experiencing frequent seizures. The extent to 
which these findings generalize to the wider community of people with epilepsy is unknown. 
Participants wore different combinations of devices for slightly different periods of time. They were 
not provided with a choice of these devices at the start of the study, so it was not possible to 
investigate participant free choice. Participants were not given real-time feedback from the research 
team about the ability of each device to detect seizures when they occurred, as data were analysed 
after the end of the recording. This will have certainly influenced their perception about accuracy and 







Obtaining feedback from patients after direct and continuous experience of wearing one or multiple 
devices, is the only way to fully understand the practical and technical issues that people with epilepsy 
face, when interacting with new technologies. From previous research we know that the effectiveness 
of the device in detecting seizures is important. From this study we now know that the visibility, the 
comfort, the possibility to remove the device and the availability of support are also all essential. 
Where discomfort was experienced, there was a risk of people deciding to discontinue wearing a 
device. Similarly, if there was any confusion about the purpose or benefit to the user, this was also a 
major barrier to continuing. The possibility to stream and share physiological data, directly from the 
device to a clinician/researcher, was generally well accepted. Stigma and fear of social exclusion are 
significant issues that still demotivate people with epilepsy when approaching and using new 
technologies. The hypothetical scenario of wearing a device at home was of interest to participants, 
suggesting that collecting data in a routine setting could be possible but the actual uptake is still 
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Table 1. Technical characteristics of wearable devices 
Device 
Name 










• Photoplethysmogram (PPG Sensor) 
[Blood Volume Pulse],  
• 3 Axis Accelerometer [Motion Base 
Activity],  
• Electrodermal Activity (EDA Sensor) 
[fluctuating changes in skin electrical 
properties], 
• Infrared Thermopile (skin temperature), 
• https://www.empatica.com/research/e4/ 























• 3-Lead electrocardiography [Heart Rate], 
• 3 Axis Accelerometer [Motion Base 
Activity],  
• Double channels electromyography 
(EMG) [muscle electrical activity],  
• Electrodermal Activity (EDA Sensor) 
























• Photoplethysmogram (PPG Sensor) 
[Blood Volume Pulse],  
• 3 Axis Accelerometer [Motion Base 
Activity],  
• Electrodermal Activity (EDA Sensor) 
[fluctuating changes in skin electrical 
properties], 














































• Photoplethysmogram (PPG Sensor) 
[Blood Volume Pulse],  
• Electrocardiogram (ECG) [Heart Rate], 
Multiple 
simultaneous 
sites (up to 5 






• 3 Axis Accelerometer and Gyroscope 
[Inertial Measurement Unit (IMU)],  
• Electrodermal Activity (EDA Sensor) 
[fluctuating changes in skin electrical 
properties], 
• Double channels electromyography 
(EMG) [muscle electrical activity],  
• Single channel electroencephalography 
(EEG). 
• https://www.byteflies.com/ 














Table 2. Demographic & Clinical Characteristics 
  
Demographic & Clinical  
Gender Female: N (%) 7 (33.3) 
Age (years): mean ± SD 40.4 ± 13.3 
Epilepsy Duration (years): mean ± SD 21.8 ± 13.5 
Self-reported seizure frequency (seizure/month): mean ± SD 22.3 ± 38.0 
Number of AEDs: mean ± SD 2.7 ± 1.1 
Period of data collection prior to interview (days) mean ± SD 3.09 ± 1.59 
Participants reporting previous experience with a wearable device N (%) 7 (33.3) 
Duration of prior experience with wearable device (months): mean ± SD 7.3 (4.5) 
Educational level completed: N (%) 
University graduate 
A level/ B-tech/ Apprenticeship (high school exams taken age 18) 
GCSE (high school exams taken age 16) 






Ethnicity: N (%) 
White 
Black/African/Caribbean/Black British 

































Table 3. Major themes, minor themes and subthemes emerging from the discussions. 

















  Support needed  
  Stable position of 
device(s) 
 
  Presence of 
wires/electrodes 
 
  Placement of 
device(s) 
 
  Removeable  
  Comfort Undisturbed by 
device(s) 
   Skin irritation or 
discomfort 
  Appearance Preferences varied 
   Discreet or 
inconspicuous 
   Fashionable fitness 
tracker 
   Like a smartwatch 
   Size of device(s) 
 Views on sharing 
data 
No problems  




   Location 









   Specialist, e.g. 
Neurologist 
    
  Leads to action Adding information to 
medical records 
   Pinpointing patterns 
   Changing medication 
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  Confusion  
  No benefit  





Use of wearables Interesting or good 
idea 
 
  Willing to take part Length of time 
   Night use 
   Home use 
   Dependent on personal 
benefit  
   Becoming part of 
routine 
  Unwilling to take 
part 
Effort 
   Crime  
   Discrimination 
  User experience Comfort 
   Ease of use 
   convenience 
   Less visible 
   Support 
   Additional feature, e.g. 
watch 
 Use of a 
smartphone app 
Value Involvement of 
family/carers 
   Simple questionnaires 
   Frequency of questions 





Table 4. Barriers and facilitators to positive user experience across all wearables, split by arm, wrist 
and flexible position devices. 
 
 
 Arm band Wrist band Flexible position device 








Presence of stickers (stuck to 
clothing, caused skin 
irritation, detached) 
 X  X  
Presence of wires (not long 
enough, nuisance when 
going to the toilet, got in the 
way) 
 X    
Needed to keep switching it 
on and unsure if device was 
working 
  X   
Battery ran out or needed to 
remember to charge or 
change device 
X  X   
Came loose (Velcro strap)  X    
Discomfort (needed to 
reposition device, caused 
skin irritation, problems 
during sleep) 
 X  X  
Too noticeable (not able to 
cover with clothes) 
 X X X  
Visible flashing light   X  X 
Cumbersome/large  X X   
Needs removing to take 
blood pressure 
X X    
Wore a watch already   X   
Limited choice of placement  X    








Removeable  X X X   
Familiar (like a watch or a 
fitness tracker) 
X  X   
Secure band X     
Practical and simple   X  X  
Able to forget that they were 
wearing the device 
X X X X X 
Right size  X    
Plastic so won’t break   X   
Discreet (can wear 
underneath clothing) 
X X   X 
Comfortable during sleep X X X   
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Supplementary file A: List of participants and devices worn. 
 
 
* Indicates participants who chose to remove the device before the end of participation in the study 



















Interviews in total 
1  X    1* 24 
2   X   4 264 
3   X   6 216 
4  X    2 44 
5 X X X   2 70 
6 X X    3 72 
7  X X   3 70 
8 X X    2 142 
9 X X X   2 138 
10 X X    2 72 
11  X    2* 49 
12 X X X   2 114 
13  X   X 5 119 
14  X  X  4 93 
15    X X 2 72 
16  X  X  2 111 
17  X  X X 2 232 
18    X X 3* 20 
19  X  X  5 48 
20   X X X 7 213 
21  X X X  4 186 
Total 6 16 8 8 5 Mean 
3.09 
(1.59) 
Mean 
112.81 
(71.83) 
